Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by 임기섭, Director. Director active across 2 companies, notably 명문제약. Cumulatively, 76 disclosures have been recorded. History available since 28 April 2026. The latest transaction was disclosed on 28 April 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Lim Gi-seop is a Board Member at Myungmoon Pharmaceutical, where he participates in the governance and strategy of the company. His role involves overseeing operations and making strategic decisions to ensure growth and sustainability at Myungmoon Pharmaceutical. With significant experience in the sector, he plays a key role in guiding the company's policies.